In Vivo Efficacy of Meropenem, with a novel non-β-lactam β-lactamase Inhibitor, Nacubactam, against Gram-negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
In Vivo Efficacy of Meropenem, with a novel non-β-lactam β-lactamase Inhibitor, Nacubactam, against Gram-negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started